Amarin Plc Stock Today

AMRN Stock  USD 0.41  0.01  2.50%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Amarin PLC is selling at 0.41 as of the 16th of March 2025; that is 2.50 percent increase since the beginning of the trading day. The stock's open price was 0.4. Amarin PLC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
1st of April 1993
Category
Healthcare
Classification
Health Care
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. The company has 414.19 M outstanding shares of which 17.05 M shares are presently shorted by private and institutional investors with about 18.83 trading days to cover. More on Amarin PLC

Moving against Amarin Stock

  0.74MLYS Mineralys Therapeutics, TrendingPairCorr
  0.65PEPG PepGenPairCorr
  0.44MRK Merck Company Sell-off TrendPairCorr
  0.35ZURA Zura Bio LimitedPairCorr
  0.32MLTX MoonLake ImmunotherapeutiPairCorr

Amarin Stock Highlights

CEO PresidentPatrick Holt
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.520.2985
Way Up
Pretty Stable
Gross Profit Margin0.720.3978
Way Up
Very volatile
Total Current Liabilities188.9 M179.9 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total18.3 M19.2 M
Notably Down
Slightly volatile
Total Assets719.6 M685.3 M
Sufficiently Up
Slightly volatile
Total Current Assets625.2 M595.4 M
Sufficiently Up
Slightly volatile
Debt Levels
Amarin PLC can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amarin PLC's financial leverage. It provides some insight into what part of Amarin PLC's total assets is financed by creditors.
Liquidity
Amarin PLC currently holds 7.72 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Amarin PLC has a current ratio of 2.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Amarin PLC's use of debt, we should always consider it together with its cash and equity.

Other Cashflows From Financing Activities

(1,330)
Amarin PLC (AMRN) is traded on NASDAQ Exchange in USA. It is located in Iconic Offices, The Greenway, Dublin, Ireland, 112-114 and employs 16 people. Amarin PLC is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 171.39 M. Amarin PLC conducts business under Biotechnology sector and is part of Health Care industry. The entity has 414.19 M outstanding shares of which 17.05 M shares are presently shorted by private and institutional investors with about 18.83 trading days to cover. Amarin PLC currently holds about 303.7 M in cash with (31.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Amarin PLC Probability Of Bankruptcy
Ownership Allocation
Amarin PLC holds a total of 414.19 Million outstanding shares. Almost 80.3 percent of Amarin PLC outstanding shares are held by general public with 1.63 (percent) owned by insiders and only 18.07 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amarin Ownership Details

Amarin Stock Institutional Holders

InstituionRecorded OnShares
Gsa Capital Partners Llp2024-12-31
1.1 M
Hayek Kallen Investment Management2024-12-31
M
Axa Sa2024-12-31
989.4 K
Lcm Capital Management, Inc2024-12-31
838.3 K
Resources Investment Advisors Inc2024-12-31
733.3 K
Raymond James Finl Svs Advisors, Inc.2024-09-30
682.5 K
Bleakley Financial Group Llc2024-12-31
468.8 K
State Street Corp2024-12-31
395.5 K
Ubs Group Ag2024-12-31
354.6 K
Sarissa Capital Management Lp2024-12-31
24.9 M
Kynam Capital Management, Lp2024-12-31
12.4 M
View Amarin PLC Diagnostics

Amarin PLC Historical Income Statement

At this time, Amarin PLC's Net Interest Income is very stable compared to the past year. View More Fundamentals

Amarin Stock Against Markets

Amarin PLC Corporate Management

Jason JDChief VPProfile
Joseph JDExec CounselProfile
Jordan ZwickSenior RelationsProfile
Alina KolomeyerDirector CommunicationsProfile
Nabil AbadirChief AffairsProfile

Already Invested in Amarin PLC?

The danger of trading Amarin PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amarin PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amarin PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amarin PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amarin PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amarin PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amarin Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amarin Plc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.94)
Earnings Share
(0.20)
Revenue Per Share
0.556
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.05)
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.